Worldwide Incidence of Autoimmune Liver Disease
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Background: The variation that occurs in the incidence patterns of autoimmune liver diseases may provide insight into the risk factors causing the diseases. We systematically reviewed studies on the incidence of autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and immunoglobulin G4-associated cholangitis (IAC) in general populations. Key Messages: We found relevant studies through Medline and Scopus, and we examined whether they were population-based; the way they found cases for inclusion and which diagnostic criteria they used; and whether they used standardization to facilitate comparison with other studies. The 55 identified studies varied greatly in their case-finding methods, and only 14 (25%) of them used a standard population. Reported incidence rates of AIH were around 1 per 100,000 population per year, possibly higher in Scandinavia than in other countries, and a Danish study of the 1994-2012 period found an increasing incidence. A majority of PBC studies found incidence rates of 1-2 per 100,000 population per year and an increasing time trend, but incidence was lower in the Netherlands and New Zealand and higher in North East England. Most studies of PSC found incidence rates around 1 per 100,000 population per year, but there were no incident cases among 100,000 Alaska natives during the period 1984-2000. The incidence of IAC remains unknown. Conclusions: The incidence of the autoimmune liver diseases is around 1-2 per 100,000 population per year for each disease. The variation in incidence over time and place suggests that there are differences in the prevalence of risk factors for the diseases, but the studies used different methods and so it is difficult to draw firm conclusions. We recommend that groups of investigators conduct multisite studies with identical case-finding methods, and that they use a standard population to account for differences in demographics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Data from multiple studies indicate that globally, an estimated 1 in 1,000 women over the age of 40 live with PBC [14].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [14]
Citations
Cites
Lok, A. S. F., & McMahon, B. J. (2007) · Hepatology · doi:10.1002/hep.21513 · Cited by 3,087
Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 1,959
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Meeting report: International autoimmune hepatitis group
Johnson, P. J., & McFarlane, I. G. (1993) · Hepatology · doi:10.1002/hep.1840180435 · Cited by 1,090
Adam, R., Karam, V., Delvart, V., O’Grady, J., Mirza, D., Klempnauer, J., Castaing, D., Neuhaus, P., Jamieson, N., Salizzoni, M., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.04.015 · Cited by 877
Age standardization of rates: a new WHO standard (GPE discussion paper Series: No. 31)
Ahmad, O., Boschi-Pinto, C., López, A. D., Murray, C. O., Lozano, R., Inoue, M., & Ahmad, O. R. A. (2002) · Cited by 844
Boonstra, K., Weersma, R. K., van Erpecum, K. J., Rauws, E. A., Spanier, B. W. M., Poen, A. C., van Nieuwkerk, K. M., Drenth, J. P., Witteman, B. J., Tuynman, H. A., et al. (2013) · Hepatology · doi:10.1002/hep.26565 · Cited by 725
K. M. BOBERG, E. A. (1998) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529850166284 · Cited by 517
Anthony, P. P., Ishak, K. G., Nayak, N. C., Poulsen, H. E., Scheuer, P. J., & Sobin, L. H. (1978) · Journal of Clinical Pathology · doi:10.1136/jcp.31.5.395 · Cited by 465
Cited by
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
“Data from multiple studies indicate that globally, an estimated 1 in 1,000 women over the age of 40 live with PBC [14].”
Primary sclerosing cholangitis – a comprehensive review
Karlsen, T. H., Folseraas, T., Thorburn, D., & Vesterhus, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.022 · Cited by 868
Lv, T., Li, M., Zeng, N., Zhang, J., Li, S., Chen, S., Zhang, C., Shan, S., Duan, W., Wang, Q., et al. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14746 · Cited by 155
Hahn, J. W., Yang, H. R., Moon, J. S., Chang, J. Y., Lee, K., Kim, G. A., Rahmati, M., Koyanagi, A., Smith, L., Kim, M. S., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102280 · Cited by 146
Cholestatic liver diseases: new targets, new therapies
Santiago, P., Scheinberg, A. R., & Levy, C. (2018) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284818787400 · Cited by 86
Grønbæk, L., Otete, H. E., Ban, L., Crooks, C. J., Card, T. R., Jepsen, P., & West, J. (2020) · Liver International · doi:10.1111/liv.14480 · Cited by 73
Self-citationBellan, M., Andréoli, L., Mele, C., Sainaghi, P. P., Rigamonti, C., Piantoni, S., Benedittis, C. D., Aimaretti, G., Pirisi, M., & Marzullo, P. (2020) · Nutrients · doi:10.3390/nu12030789 · Cited by 80
“presents with non-suppurative granulomas [232,233], and primary sclerosing cholangitis (PSC), affecting mainly young men with both small and large bile ducts involvement [234].”
BackgroundRole of circulating microRNAs in liver diseases
Loosen, S. H., Schueller, F., Trautwein, C., Roy, S., & Roderburg, C. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i12.586 · Cited by 69
Fibrotic Events in the Progression of Cholestatic Liver Disease
Wu, H., Chen, C., Ziani, S., Nelson, L. J., Avila, M. A., Nevzorova, Y. A., & Cubero, F. J. (2021) · Cells · doi:10.3390/cells10051107 · Cited by 65
Guerra, I., Bujanda, L., Castro, J., Merino, O., Tosca-Cuquerella, J., Camps, B., Gutiérrez, A., Gordillo, J., de Castro, L., Iborra, M., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz094 · Cited by 55
Antibodies to gp210 and understanding risk in patients with primary biliary cholangitis
Haldar, D., Janmohamed, A., Plant, T. D., Davidson, M., Norman, H., Russell, E. A., Serevina, O., Chung, K., Qamar, K., Gunson, B. K., et al. (2020) · Liver International · doi:10.1111/liv.14688 · Cited by 67
Gazda, J., Dražilová, S., Janíčko, M., & Jarčuška, P. (2021) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2021/9151525 · Cited by 61
“According to one report, approximately one in 1,000 women could be suffering from PBC [30].”
BackgroundFamily occurrence of autoimmune hepatitis: A Danish nationwide registry-based cohort study
Grønbæk, L., Vilstrup, H., Pedersen, L., Christensen, K., & Jepsen, P. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.035 · Cited by 50
“In our previous study, we found the same AIH prevalence and incidence as worldwide reported (1, 19).”
BackgroundResultSelf-citationActivation of Nrf2 and FXR via Natural Compounds in Liver Inflammatory Disease
Belka, M., Gostyńska, A., Stawny, M., & Krajka‐Kuźniak, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011213 · Cited by 57
“Autoimmune hepatitis, though less common, has an estimated incidence of 1–2 cases per 100,000 people annually in regions like Europe and North America [5].”
BackgroundRheumatic Manifestations in Autoimmune Liver Disease
Selmi, C. F., Generali, E., & Gershwin, M. E. (2017) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2017.09.008 · Cited by 50
Contemporary epidemiology of primary biliary cholangitis
Colapietro, F., Bertazzoni, A., & Lleo, A. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.06.001 · Cited by 43
TGF-β2 silencing to target biliary-derived liver diseases
Dropmann, A., Dooley, S., Dewidar, B., Hammad, S., Dediulia, T., Werle, J., Hartwig, V., Ghafoory, S., Wölfl, S., Korhonen, H., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319091 · Cited by 44
First-Degree Living-Related Donor Liver Transplantation in Autoimmune Liver Diseases
Aravinthan, A. D., Doyle, A. C., Issachar, A., Dib, M. J., Peretz, D., Cattral, M. S., Ghanekar, A., McGilvray, I. D., Selzner, M., Greig, P. D., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13828 · Cited by 39
“Diagnostic criteria of disease recurrence following LT PSC: Diagnosis of recurrence of PSC was made according to the Mayo Clinic criteria, as proposed by Graziadei et al (23), which require (1) confirmed diagnosis of PSC before LT; (2) either cholangiography showing biliary stricturing, beading, and irregularities at…”
BackgroundMethodInfluentialAutoimmune hepatitis — update on clinical management in 2017
Liwinski, T., & Schramm, C. (2017) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2017.07.002 · Cited by 38
Sebode, M., Kloppenburg, A. G., Aigner, A., Lohse, A. W., Schramm, C., & Linder, R. (2020) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1135-9306 · Cited by 35
Акберова, Д. Р., Kiassov, A. P., & Abdulganieva, D. I. (2017) · Journal of Immunology Research · doi:10.1155/2017/9829436 · Cited by 37
Autoimmune Liver Disease in Children with Sickle Cell Disease
Jitraruch, S., Fitzpatrick, E., Deheragoda, M. G., Deganello, A., Mieli‐Vergani, G., Height, S. E., Rees, D. C., Hadžić, N., & Samyn, M. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.06.035 · Cited by 34
Yu, Q., Liu, T., Li, S., Feng, J., Wu, L., Wang, W., Chen, K., Xia, Y., Niu, P., Xu, L., et al. (2018) · Mediators of Inflammation · doi:10.1155/2018/4032484 · Cited by 35
Bossen, L., Gerussi, A., Lygoura, V., Mells, G. F., Carbone, M., & Invernizzi, P. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.02.013 · Cited by 35
Potential Crosstalk between Liver and Extra-liver Organs in Mouse Models of Acute Liver Injury
Zheng, Y., Cui, B., Sun, W., Wang, S., Huang, X., Gao, H., Gao, F., Cheng, Q., Lü, L., An, Y., et al. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.41293 · Cited by 33
“Owing to the increasing incidence of autoimmune hepatitis (AIH) worldwide [12], the model of AIH is widely needed for scientific research.”
BackgroundThe risk of liver cancer in autoimmune liver diseases
Lleò, A., de Boer, Y. S., Liberal, R., & Colombo, M. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919861914 · Cited by 33
Cao, H., Zhu, B., Qu, Y., & Zhang, W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02815 · Cited by 25
“age of 40 live with PBC, and the estimated incidence is between 1 and 2 per 100,000 population per year in European populations (3); commonly cited ranges for incidence and prevalence are 0.”
BackgroundGrønbæk, L., Vilstrup, H., Pedersen, L. H., & Jepsen, P. (2018) · Liver International · doi:10.1111/liv.13963 · Cited by 28
Self-citationChen, S., Duan, W., Li, M., Li, S., Lv, T., Tian, Q., Wang, Q., Wu, X., Zhao, X., Wang, X., et al. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14521 · Cited by 25
Ultrasound findings in autoimmune hepatitis
Dong, Y., Potthoff, A., Klinger, C., Barreiros, A. P., Pietrawski, D., & Dietrich, C. F. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i15.1583 · Cited by 23
Patten, D. A., & Shetty, S. (2019) · Biomolecules · doi:10.3390/biom9070283 · Cited by 24
“In addition to the increasing incidence of non-alcoholic steatohepatitis (NASH; fatty liver disease) and alcohol-related liver disease (ARLD) [2], other aetiologies, such as viral hepatitis and autoimmune liver diseases, are also contributing to the rising occurrence of chronic liver disease [3,4].”
BackgroundThe Liver in Sickle Cell Disease
Lacaille, F., Allali, S., & de Montalembert, M. (2020) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002886 · Cited by 22
“As the incidence of autoimmune diseases, especially liver and inflammatory bowel diseases, is increasing worldwide (31), more cases will probably be diagnosed in SCD, as we are recently experiencing.”
BackgroundNon‐amyloid liver involvement in familial Mediterranean fever: A systematic literature review
Fraisse, T., Savey, L., Hentgen, V., Rossi‐Semerano, L., Koné‐Paut, I., Grateau, G., Georgin‐Lavialle, S., & Ducharme‐Bénard, S. (2020) · Liver International · doi:10.1111/liv.14445 · Cited by 22
Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives
Villani, R., Serviddio, G., Avolio, C., Cassano, T., & D’Amico, E. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01128-8 · Cited by 17
The impact of infections on delisting patients from the liver transplantation waiting list
Alferink, L. J. M., Oey, R. C., Hansen, B. E., Polak, W. G., van Buuren, H. R., de Man, R. A., Schurink, C. A. M., & Metselaar, H. J. (2017) · Transplant International · doi:10.1111/tri.12965 · Cited by 16
“The high incidence of PSC could explain the relative high frequency of cholangitis compared to other studies [23,24].”
ResultEpidemiology and clinical course of primary biliary cholangitis in Eastern Slovakia
Eastern Slovakia PBC Group, Dražilová, S., Babinská, I., Gazda, J., Halánová, M., Janíčko, M., Kucinsky, B., Šafčák, D., Martinkova, D., Tarbajova, L., et al. (2020) · International Journal of Public Health · doi:10.1007/s00038-020-01391-6 · Cited by 20
Diagnostic Performance of Shear Wave Elastography in Patients With Autoimmune Liver Disease
Li, C., Dhyani, M., Bhan, A. K., Grajo, J. R., Pratt, D. S., Gee, M. S., & Samir, A. E. (2018) · Journal of Ultrasound in Medicine · doi:10.1002/jum.14668 · Cited by 14
Primary biliary cholangitis is more severe in previous hepatitis B virus infection patients
Zhang, Y., Shi, Y., Wu, R., Wang, X., Gao, X., & Niu, J. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001100 · Cited by 13
Two decades of research on autoimmune liver disease in Turkey
Demir, N., Ekin, N., Torğutalp, M., Wåhlin, S., & Efe, C. (2020) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2020.19866 · Cited by 15
“Several recent studies have reported that the incidence of AILD is increasing worldwide (5, 6).”
BackgroundIncreased Intrahepatic Expression of Immune Checkpoint Molecules in Autoimmune Liver Disease
Jílková, Z. M., Hilleret, M., Gerster, T., Stürm, N., Mercey-Ressejac, M., Zarski, J., Leroy, V., Marche, P. N., Costentin, C. E., & Decaens, T. (2021) · Cells · doi:10.3390/cells10102671 · Cited by 15
George, E. B., Rosline, G. J., Varghese, A., & Rajesh, G. (2024) · Technology Innovation Management and Engineering Science International Conference (TIMES-iCON) · doi:10.1109/times-icon61890.2024.10630757 · Cited by 15
“Autoimmune hepatitis (AIH) is a chronic liver infection that frequently has no known cause but still it occurs in many patients[6].”
BackgroundRecurrent Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Directions
Leung, K. K., Deeb, M., Fischer, S. E., & Gulamhusein, A. F. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1730950 · Cited by 12
Epidemiology of autoimmune liver disease in Korea: evidence from a nationwide real-world database
Lim, J., & Kim, H. J. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03086-0 · Cited by 12
“These discrepancy are based on the study limitations; for example, some were only hospital or community-based and used ambiguous disease definitions [7].”
BackgroundInfluentialCheng, J., Chen, W., Ku, H., Chien, R., & Chang, M. (2023) · Hepatology Research · doi:10.1111/hepr.13910 · Cited by 10
“For example, the PBC prevalence rate is higher in northern than southern Italy,(24) and incidence rates of PBC are high in North America and Northern Europe(7) but low in the Netherlands and New Zealand.(33) Consistently, higher relative risks of PBC incidence rates were noted among northern than southern residents in…”
BackgroundNielsen, K. R., Midjord, J., Johannesen, H. L., & Grønbæk, H. (2023) · International Journal of Circumpolar Health · doi:10.1080/22423982.2023.2221368 · Cited by 10
“There was no incident PSC patient among natives in Alaska [6], while the incidence and”
BackgroundInfluentialPredictors of survival in autoimmune liver disease overlap syndromes
Jayabalan, D., Huang, Y., Bertot, L. C., Janjua, M., de Boer, B., Joseph, J., Cheng, W., Hazeldine, S., Smith, B. W., MacQuillan, G. C., et al. (2024) · World Journal of Hepatology · doi:10.4254/wjh.v16.i9.1269 · Cited by 9
Liver fibrotic burden across the spectrum of hypothyroidism
Du, T., Huang, Y., Lv, Y., & Yuan, G. (2024) · Journal of Gastroenterology · doi:10.1007/s00535-024-02184-x · Cited by 10
Guatibonza-García, V., Gaete, P. V., Pérez-Londoño, A., Puerto-Baracaldo, D. K., Gutiérrez-Romero, S. A., Mendivil, C. O., & Tapias, M. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i29.4890 · Cited by 11
Cirrhosis epidemiology in Denmark 1998–2022, and 2030 forecast
Kornerup, L. S., Kraglund, F., Askgaard, G., Vilstrup, H., & Jepsen, P. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101353 · Cited by 7
“25,26 However, we do not have data on these speci fi c diagnoses, which is a limitation of our study.”
Self-citationA Closer Look into Autoimmune Liver Diseases
Filipović, B. F., Marjanovic-Haljilji, M., Blagojevic, D., Dragovic, M., Krsmanovic, E., Matovic, A., Panic, N., Kiurski, S., Zagorac, Z., Milanović, M., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051863 · Cited by 9
Mortality in Autoimmune Liver Disease in Sweden: A Population‐Based Cohort Study of 9,654 Patients
Lasyte, I., Widman, L., Bergquist, A. M., & Hagström, H. (2025) · Liver International · doi:10.1111/liv.70007 · Cited by 7
(2022) · British Journal of Gastroenterology · doi:10.31488/bjg.1000128 · Cited by 10
Autoimmune Hepatitis: Diagnostic Dilemma When It Is Disguised as Iron Overload Syndrome
Acharya, G. K., Liao, H.-I., Frunza-Stefan, S., Patel, R., & Khaing, M. (2017) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2017.03.006 · Cited by 8
“The incidence of AIH is around 1 per 100,000 population per year.(3) Given this rarity, the diagnosis can be further complicated by a similar presentation of iron overload syndrome.”
BackgroundWang, H., Zhang, J., Liu, J., Jiang, Y., Fu, L., & Peng, S. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1124956 · Cited by 5
“Approximately 1 in 1000 women over the age of 40 years live with PBC (Jepsen et al., 2015).”
BackgroundZhang, W., & Lang, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1276459 · Cited by 7
“The prevalence and annual incidence rate of PSC are estimated to be approximately 1 per 10,000 and 0.4 to 20 cases per 100,000 per year in the US and Northern Europe, respectively (3, 4).”
BackgroundInfluentialWang, Y., Li, Y., Wang, X., Gaćeša, R., Zhang, J., Zhou, L., & Wang, B. (2020) · Disease Markers · doi:10.1155/2020/8460883 · Cited by 7
“Since AILD is a rare disease (prevalence of 1-2 per 100,000 worldwide [32]), our models were, by necessity, designed using relatively small samples and an unbalanced ratio of cases and controls.”
BackgroundBaldovino, S., Menegatti, E., Roccatello, D., & Sciascia, S. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67144-4_26 · Cited by 5
Tamimi, T., Sallam, M., Rayyan, D., Farah, R., Alkhulaifat, D., Al-Ani, A. T., Elmusa, R., Sharawi, S., Tanash, O., & Rayyan, Y. M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020629 · Cited by 8
“0 per 100,000 individuals per year, while its prevalence ranges from 4 to 25 per 100,000 individuals [12,13].”
BackgroundAzzam, N. A., AlRuthia, Y. S., Alharbi, O., Aljebreen, A., Almadi, M. A., & Loftus, E. V. (2020) · Hepatology International · doi:10.1007/s12072-020-10110-5 · Cited by 5
Lawson, K. L., & Wang, H. L. (2023) · Surgical pathology clinics · doi:10.1016/j.path.2023.04.008 · Cited by 4
Salivary immunoglobulin levels in juvenile autoimmune hepatitis
Damasceno, J. X., Guedes, M. I. F., Leite, C. A. C., Monteiro, A. J., Fonteles, M. C., Jimenez, M. E. Z., Lima, V., Ribeiro, T. R., & Fonteles, C. S. R. (2018) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2018.04.014 · Cited by 4
Primary Biliary Cholangitis and Ursodeoxycholic Acid: Therapy Progress and Challenges
Vinnitskaya, E. V., Absandze, K. G., Архипова, Е. В., Ivanov, A. N., Сергеевна, С. Е., & Sandler, Y. G. (2019) · Doctor Ru · doi:10.31550/1727-2378-2019-158-3-33-39 · Cited by 4
“Результаты исследований показывают, что по всему миру примерно 1 из 1000 женщин старше 40 лет имеет ПБХ [12].”
Chen, J., Liu, Y., Bi, Y., & Wang, X. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i29.4580 · Cited by 9
Primary Sclerosing Cholangitis
Vesterhus, M. N., & Karlsen, T. H. (2019) · Wiley eBooks · doi:10.1002/9781119211419.ch40 · Cited by 4
Khan, A. A., Haq, F. U., Wahab, Q. M. F., Aslam, T., Khalid, A., & Ali, A. A. B. (2025) · Cureus · doi:10.7759/cureus.79582 · Cited by 3
“It affects people of all races, ethnicities, and countries worldwide, and its incidence and prevalence are rising, particularly among women [2,3].”
Dias, B., Aguiar, A., Morais, C. I., & Nery, F. (2023) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002565 · Cited by 6
Abdallah, R. A., Shaban, M. I., Taie, D. M., Asaad, N. Y., & Badr, A. (2019) · Turkish Journal of Pathology · doi:10.5146/tjpath.2019.01463 · Cited by 4
“3) Grades of necro-inflammatory changes (HAI grading) were grouped into two categories for statistical purposes: minimal/mild activity; score (1-8) and moderate/severe activity; score (9-18).”
BackgroundAntimitochindrial and antinuclear antibodies in primary biliary cholangitis
Saipiyeva, D., Askarov, M. B., Tuganbekov, T., Rustemova, K., Grigorevsky, V., Dossatayeva, G. S., & Tostanovskaya, N. (2019) · Journal of Clinical Medicine of Kazakhstan · doi:10.23950/1812-2892-jcmk-00681 · Cited by 3
Wang, Z.-L., Song, K.-M., Jin, R., Xie, Y.-D., Wang, Y.-Q., Liu, Z.-C., & Feng, B. (2022) · Medicine · doi:10.1097/md.0000000000028987 · Cited by 3
“Data from multiple research centers showed that one in 1000 women over 40years old worldwide had PBC.([2]) It was previously believed that PBC was relatively rare in China.”
BackgroundInfluentialБакулин, И. Г., Burlakova, S. A., Васильевна, С. Е., & Skalinskaya, M. I. (2024) · HERALD of North-Western State Medical University named after I I Mechnikov · doi:10.17816/mechnikov627505 · Cited by 2
Chen, Z., Hong, W., Yang, X., Hu, W., & Fang, T. (2025) · Medicine · doi:10.1097/md.0000000000046666 · Cited by 2
Primary biliary cholangitis: symptoms, diagnosis and treatment
Mortimore, G. (2017) · Gastrointestinal Nursing · doi:10.12968/gasn.2017.15.sup5.s12 · Cited by 2
Proteomics in Primary Biliary Cholangitis
Li, Y., Tang, R., Leung, P. S. C., Gershwin, M. E., & Ma, X. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9420-5_11 · Cited by 2
Papel del ácido ursodesoxicólico en 40 años de tratamiento para la colangitis biliar primaria
Montoya-Orozco, P. A., & Moreno-Cuadros, A. L. (2023) · Hepatología · doi:10.59093/27112322.174 · Cited by 2
Primary Biliary Cholangitis in Elderly: About 12 Tunisian Cases
Lamine, Z. B., Mankaï, A., Ahmed, M. B., Jazia, I. B., Slama, A. B., Baccouhe, A., Jemaa, A., & Ghédira, I. (2018) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000564 · Cited by 2
(2022) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477183-8 · Cited by 2
Ethnic and Racial Differences in Autoimmune Liver Diseases
Freire, A., & Levy, C. (2018) · Current Hepatology Reports · doi:10.1007/s11901-018-0399-5 · Cited by 2
“Zolfino and colleagues conducted a retrospective study of all non-European Caucasoid (EC) patients attending their liver clinics at King’s College Hospital between 1983 and 1999 and found that non-EC presented at a younger age, had a predominance of cholestatic biochemistry and had poorer initial response to standard…”
BackgroundResultInfluentialPPAR agonists for primary biliary cholangitis
Gossard, A. A., & Gores, G. J. (2017) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(17)30256-x · Cited by 2
Overlap syndrome in hepatology
Yarmolenko, O. A., Малаева, Е. Г., Мамченко, И. Л., Aleynikova, T. V., Кобрусева, Л. А., Худяков, И. А., Меньшакова, М. Н., & Malashchenko, E. I. (2023) · Health and Ecology Issues · doi:10.51523/2708-6011.2023-20-2-17 · Cited by 1
Autoimmune Hepatitis and Immune-Mediated Cholestatic Liver Diseases
Czaja, A. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-94355-8_16 · Cited by 2
Current paradigm and treatment options for autoimmune hepatitis
Kornerup, L. S., Grønbæk, L., Kjær, M. B., & Grønbæk, H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98368-6.00026-4 · Cited by 1
Self-citationMembrane application for liver support devices
Novelli, S., Engelman, C., & Piemonte, V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814225-7.00002-4 · Cited by 1
17-year-old girl • abdominal pain • lower-leg itching • dark urine and yellow eyes • Dx?
Gillis (2020) · The Journal of Family Practice · doi:10.12788/jfp.0120 · Cited by 1
Karlsen, T. H., & Boberg, K. M. (2018) · Wiley eBooks · doi:10.1002/9781119237662.ch18 · Cited by 1
Primary biliary cholangitis: From diagnosis to treatment
Guarino, M. (2018) · Annals of Gastroenterology and the Digestive System · doi:10.33582/2637-4501/1001 · Cited by 1
Panda, A. K., Choudhury, A. K., & Hazra, J. (2020) · International Research Journal of Ayurveda & Yoga · doi:10.47223/irjay.2020.3913
Recurrent Severe Hepatitis of Autoimmune Origin
Krstevski, G., Ivanova, V. C., Andreevski, V., & Serafimovski, V. (2021) · PRILOZI · doi:10.2478/prilozi-2021-0007
Ruiz, A. L., & Morán, G. A. G. (2017) · Revista Médica Sanitas
Inflammatory Hepatobiliary Diseases
Selmi, C. F., Manns, M. P., & Gershwin, M. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-7020-6896-6.00076-4
Autoimmune Hepatitis Disguised as Iron Overload Syndrome: Diagnostic Dilemma in a Nigerian Man
Ugonabo, O. S., & Chudy‐Onwugaje, K. (2023) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/23247096231175442 · Cited by 2
Epidemiology of Alcohol-Related Liver Disease in Europe
Jepsen, P. (2023) · Springer eBooks · doi:10.1007/978-3-031-32483-3_3
Self-citationPerceived Stigma in Patients with Autoimmune Hepatitis
Naftaly, J. P., Feldman, E. C. H., & Greenley, R. N. (2023) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-023-09983-z
“Autoimmune hepatitis (AIH) is an autoimmune liver disease that impacts 1 in 100,000 patients (Jepsen et al., 2015).”
Lim, J., & Kim, H. J. (2024) · Figshare · doi:10.6084/m9.figshare.25720152
Ashraf, B., Gornick, D., Sumbal, W., Saeed, Z., PEREDO, R. A., & Tadros, M. S. (2025) · Clinical gastroenterology · doi:10.1007/978-3-032-07868-1_10
Mechanism of FXR signaling: from liver inflammation to hepatocellular carcinoma
Qiuluo, C., Huang, G., Xue, H., & Zhu, Y. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102753
“Related epidemiological studies have found that the annual incidence of autoimmune hepatitis in Europe and North America is around 1-2 cases per 100,000 individuals [12].”
Metadata
- Authors
- Jepsen, P., Grønbæk, L., & Vilstrup, H.
- Affiliations
- Aarhus University Hospital (DK)
- Venue
- Digestive Diseases
- Publisher
- S. Karger AG
- Published
- 2015
- Volume
- 33
- Issue
- Suppl. 2
- Pages
- 2-12
- ISSN
- 0257-2753 (ISSN-L)
- 1421-9875
- OpenAlex
- W2196324096
- Cited by
- 95
- References
- 62
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 7 · 2023: 16 · 2022: 4 · 2021: 6 · 2020: 14 · 2019: 12 · 2018: 15 · 2017: 13 · 2016: 1
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Digestive Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- autoimmune liver disease, incidence, autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, incidence trends, regional variation, standard population, risk factors
- MeSH terms
- Autoimmune Diseases, Cholangitis, Humans, Immunoglobulin G, Liver Cirrhosis, Biliary, Liver Diseases, Risk Factors, Cholangitis, Sclerosing, Incidence, Hepatitis, Autoimmune
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.